(NASDAQ: WBA) Walgreens Boots Alliance's forecast annual revenue growth rate of 2.14% is forecast to beat the US Pharmaceutical Retailers industry's average forecast revenue growth rate of 2.14%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.87%.
Walgreens Boots Alliance's revenue in 2024 is $147,658,000,000.On average, 7 Wall Street analysts forecast WBA's revenue for 2025 to be $128,882,869,391,629, with the lowest WBA revenue forecast at $127,663,313,095,890, and the highest WBA revenue forecast at $130,042,739,437,650. On average, 6 Wall Street analysts forecast WBA's revenue for 2026 to be $131,893,801,709,736, with the lowest WBA revenue forecast at $128,846,109,329,730, and the highest WBA revenue forecast at $134,916,586,199,460.
In 2027, WBA is forecast to generate $136,500,186,943,934 in revenue, with the lowest revenue forecast at $131,411,687,739,579 and the highest revenue forecast at $140,587,955,801,982.